PAM
CMPX icon

Panagora Asset Management’s Compass Therapeutics CMPX Stock Holding History

Panagora Asset Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Buy
+222,179
New +$656K ﹤0.01% 903
2025
Q3 		– Sell
-15,840
Closed -$41.2K – 1171
2025
Q2 		$41.2K Sell
15,840
-154,767
-91% -$319K ﹤0.01% 1106
2025
Q1 		$324K Sell
170,607
-859
-0.5% -$2.28K ﹤0.01% 917
2024
Q4 		$249K Buy
171,466
+29,855
+21% +$49.6K ﹤0.01% 1009
2024
Q3 		$261K Buy
141,611
+73,343
+107% +$91.4K ﹤0.01% 1078
2024
Q2 		$68.3K Buy
+68,268
New +$99.7K ﹤0.01% 1169

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Panagora Asset Management's CMPX Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Compass Therapeutics (CMPX) in Q2 2026: 222,179 shares worth $487K. The stake represents ﹤0.01% of the portfolio and ranks #903 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in CMPX as recently as Q2 2025.

Panagora Asset Management first reported a position in CMPX in Q2 2024 and has held it in 6 quarters since. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Panagora Asset Management held 222,179 shares of Compass Therapeutics worth $487K as of Q2 2026.
  • Compass Therapeutics was a new Panagora Asset Management position in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #903 holding.
  • Panagora Asset Management first reported a position in Compass Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.